This page is an in-depth guide about all the IVIG brands and their major differences. IVIG is the acronym for Intravenous Immune globulin and is mainly given in autoimmune or immunological disorders (diseases in which your immune system attacks your
Guillain-Barre Syndrome is a rare, rapid onset neurological condition in which the body’s immune system attacks peripheral nerve cells, possibly leading to paralysis. This autoimmune disorder affects the arms and legs, and early symptoms include pain, weakness, and numbness.
Immunoglobulins were initially called neutralizing substances, and they were discovered in 1890 by two immunologists, Emil von Behring and Kitasato Shibasaburo. Immunoglobulins are special types of glycoproteins that play an important role in maintaining the body's immune system. Also called
Cuvitru (generic name: immune globulin ) is derived from human plasma and it is indicated to protect patients with antibodies insufficiency against infections. This medicine belongs to the immune globulins drug class. Cuvitru is FDA approved  to be used
Decitabine is a chemotherapy (anticancer) drug available under the brand name "Dacogen." This anticancer drug is typically prescribed for adult patients suffering from myelodysplastic syndromes (MDS). Each year, around 10,000 people are diagnosed with myelodysplastic syndromes (MDS) in the United
Hyperalimentation (pronounced as HY-per-A-lih-men-TAY-shun) is a method of providing a high-calorie and nutrient-rich solution to patients with bowel obstruction or resection. Historically, the concept of hyperalimentation can trace back to the 1960s when Dr. Stanley J. Dudrick, an American surgeon,
Total parenteral nutrition (TPN), commonly known as intravenous feeding, is typically recommended by doctors to cancer patients to fulfill their nutritional requirements. It is given under certain conditions, such as when tube feeding is not feasible, or patients experience gastrointestinal
Guillain-Barre is a rare but serious autoimmune condition. It affects the nerves and can sometimes be life-threatening. While no known cure exists, treatments such as IVIG are available for Guillain-Barre disease. People can make a full recovery by receiving treatment early.
Kawasaki disease (KD) is a rare heart condition that mainly affects children. In the US, 9 to 20 children out of every 100,000 are diagnosed with this condition each year. If left untreated, Kawasaki disease can cause lasting damage to